{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T03:19:15Z","timestamp":1725851955923},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:00:00Z","timestamp":1342137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00277-012-1518-y","type":"journal-article","created":{"date-parts":[[2012,7,22]],"date-time":"2012-07-22T03:14:04Z","timestamp":1342926844000},"page":"1757-1763","source":"Crossref","is-referenced-by-count":6,"title":["Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma"],"prefix":"10.1007","volume":"91","author":[{"given":"Dong Ta","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Mei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Ze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Gang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,13]]},"reference":[{"key":"1518_CR1","first-page":"390","volume":"27","author":"JJ Goedert","year":"2000","unstructured":"Goedert JJ (2000) The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27:390\u2013401","journal-title":"Semin Oncol"},{"key":"1518_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.1989.03420050069041","volume":"261","author":"LD Kaplan","year":"1989","unstructured":"Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P et al (1989) AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261:719\u2013724","journal-title":"JAMA"},{"issue":"14","key":"1518_CR3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328(14):1002\u20131006","journal-title":"N Engl J Med"},{"key":"1518_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3816\/CLM.2004.n.009","volume":"5","author":"C Emmanoulides","year":"2004","unstructured":"Emmanoulides C, Colovos C, Pinter-Brown L, Hernandez L, Schiller G, Territo M et al (2004) Pilot study of fixed infusion rate gemcitabine with cisplatin and dexamethasone in patients with relapsed or refractory lymphoma. Clin Lymphoma 5:45\u201349","journal-title":"Clin Lymphoma"},{"key":"1518_CR5","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/annonc\/mdg496","volume":"14","author":"T Baetz","year":"2003","unstructured":"Baetz T, Belch A, Couban S, Imrie K, Yau J, Myers R et al (2003) Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 14:1762\u20131767","journal-title":"Ann Oncol"},{"key":"1518_CR6","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/cncr.20587","volume":"101","author":"M Crump","year":"2004","unstructured":"Crump M, Baetz T, Couban S, Belch A, Marcellus D, Howson-Jan K et al (2004) Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). Cancer 101:1835\u20131842","journal-title":"Cancer"},{"key":"1518_CR7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1046\/j.1365-2141.2003.04226.x","volume":"120","author":"I Chau","year":"2003","unstructured":"Chau I, Harries M, Cunningham D, Hill M, Ross PJ, Archer CD et al (2003) Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma. Br J Haematol 120:970\u2013977","journal-title":"Br J Haematol"},{"key":"1518_CR8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffler B, Shipp MA, Fisher RI, Connors JM et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 17:1244","journal-title":"J Clin Oncol"},{"key":"1518_CR9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella","year":"1998","unstructured":"Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853\u2013860","journal-title":"N Engl J Med"},{"key":"1518_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/QAI.0b013e31802bb5d0","volume":"44","author":"P Miralles","year":"2007","unstructured":"Miralles P, Berenguer J, Ribera JM, Rubio R, Mahillo B, T\u00e9llez MJ et al (2007) Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors. J Acquir Immune Defic Syndr 44:167\u2013173","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1518_CR11","first-page":"6823","volume":"50","author":"R Grunewald","year":"1990","unstructured":"Grunewald R, Kanraejan H, Keating MJ, Abbruzzese J, Tarassoff P, Plungett W (1990) Pharmacologically directed design of the dose rate and schedule of 2\u2032, 2\u2032-difluorodeoxycitidine (gemcitabine) administration in leukemia. Cancer Res 50:6823\u20136826","journal-title":"Cancer Res"},{"key":"1518_CR12","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1200\/JCO.1999.17.12.3786","volume":"17","author":"A Fossa","year":"1999","unstructured":"Fossa A, Santoro A, Hiddemann W, Truemper L, Niederle N, Buksmaui S et al (1999) Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma. J Clin Oncol 17:3786\u20133792","journal-title":"J Clin Oncol"},{"key":"1518_CR13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2141.2001.02795.x","volume":"113","author":"C Dumontet","year":"2001","unstructured":"Dumontet C, Morschhauser F, Solal-Celigny P, Bouafia F, Bourgeois E, Thieblemont C et al (2001) Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma. Br J Haematol 113:772\u2013778","journal-title":"Br J Haematol"},{"key":"1518_CR14","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1200\/JCO.2000.18.13.2603","volume":"18","author":"PL Zinzani","year":"2000","unstructured":"Zinzani PL, Baliva G, Magagnoli M, Bendandi M, Modugno G, Gherlinzoni F et al (2000) Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients. J Clin Oncol 18:2603\u20132606","journal-title":"J Clin Oncol"},{"key":"1518_CR15","first-page":"16","volume":"23","author":"GJ Peters","year":"1996","unstructured":"Peters GJ, Ruiz van Haperen VW, Bergman AM, Veerman G, Smitskamp-Wilms E, van Moorsel CJ et al (1996) Preclinical combination therapy with gemcitabine and mechanisms of resistance. Semin Oncol 23:16\u201324","journal-title":"Semin Oncol"},{"key":"1518_CR16","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","volume":"101","author":"RF Little","year":"2003","unstructured":"Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H et al (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101:4653\u20134659","journal-title":"Blood"},{"key":"1518_CR17","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","volume":"19","author":"L Ratner","year":"2001","unstructured":"Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B et al (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19:2171\u20132178","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1518-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1518-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:26Z","timestamp":1559037026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1518-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,13]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1518-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,13]]}}}